Skip to content

Expanding the Use of the TB LAM Test for People with HIV

  • Dorrit Walsh

TAG and partners hosted this webinar on October 3, 2017.  Speakers included Lynette Mabote, AIDS & Rights Alliance for Southern Africa; Lindiwe Mvusi, Department of Health,  Republic of South Africa; Stephen Wanjala, MSF; and Wayne van Gemert, Global Drug Facility…

Read more

TAG Letter to House E&C Committee Opposing “Right to Try” Bills

  • Chad Cipiti

TAG’s comments to the Health Subcommittee of the U.S. House of Representatives Energy and Commerce Committee, in association with its hearing, “Examining Patient Access to Investigational Drugs,” and the deliberations of H.R. 1020, the Compassionate Freedom of Choice Act of 2017, and S. 204, the Right to Try Act of 2017.

Read more

The TB Prevention Pipeline

  • Chad Cipiti

July 2017 By Mike Frick INTRODUCTION One of the tuberculosis (TB) field’s most often voiced truisms has been that one-third of humanity is infected with Mycobacterium tuberculosis (MTB), the causative agent of TB disease. This estimate is invoked so frequently…

Read more

The Tuberculosis Diagnostics Pipeline

  • Chad Cipiti

July 2017 By Erica Lessem INTRODUCTION Diagnosing tuberculosis (TB) is the first step to being able to treat it and prevent transmission. New guidelines from the World Health Organization (WHO) note that diagnosis should be “available free of charge to…

Read more
Back To Top